Sort
21,281 grants matching “influenza”
Surveillance/Response to Avian /Pandemic Influenza By National Health Authorities
$250,000David Mwenda Mutonga · Ministry Of Health Kenya · U51 · FY2010 · CI
Surveillance and Response to Avian and Pandemic Influenza
$250,000Filomewa Gomes Dasilva · Ministry Of Health · U51 · FY2010 · CI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)
$250,000Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2018 · IP
EFFICACY OF OSELTAMIVIR IN REDUCING DURATION OF ILLNESS, VIRAL SHEDDING & TRANSIS
$250,000W. Abdullah Brooks · International Ctr/Diarrhoeal Dis Res · U01 · FY2009 · IP
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS (TRAILBLAZER FUNDS FOR NC)
$250,000Kenes Ospanov · Republican Sanitary & Epidemiol Station · U50 · FY2006 · CI
Enhanced Surveillance for New Vaccine Preventable Diseases
$250,000Julie Anne Boom · Texas Children'S Hospital · U01 · FY2018 · IP
Surveillance and Response to Avian and Pandemic Influenza
$250,000Filomewa Gomes Dasilva · Ministry Of Health · U51 · FY2009 · CI
RFA-GH-19-004, Advancing Public Health Research in Bangladesh
$250,000Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2022 · GH
Clinical Trial of Oseltamivir Efficacy for Reducing Influenza Severity
$250,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2010 · IP
Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic
$250,000Jose Marins · Fiotec · U51 · FY2014 · IP
Characterization of the Evolution of Influenza A Viruses
$250,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2015 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$250,000Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2020 · AI
PREPAREDNESS AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA IN ZAMBIA
$250,000Davy Chikamata · Ministry Of Health Zambia · U51 · FY2012 · IP
Household Transmission of Influenza Viruses in the Community
$250,000Carlos G Grijalva · Vanderbilt University Medical Center · U01 · FY2019 · IP
Airway epithelial defense and interferon
$249,999Michael Jay Holtzman · Washington University · U19 · FY2016 · AI
First-in-class small molecules that enhance lung barrier function during acute respiratory distress syndrome (ARDS) as potential therapeutics for COVID-19
$249,998Frederick M Ausubel · Artus Therapeutics Inc · R43 · FY2021 · HL
LEAPS-MPS: Refining Inverse Methods and Advancing Hybrid Forecasting Approaches for Influenza Transmission Dynamics
$249,993Xiunan Wang · University Of Tennessee Chattanooga · · FY2025 · MPS
Molecular regulation of the AP2 clathrin adaptor complex
$249,930Gunther Hollopeter · Cornell University · R01 · FY2022 · GM
Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
$249,863Kristina Abel · Univ Of North Carolina Chapel Hill · R21 · FY2023 · AI
Development of the New Synthetic Triterpenoid CDDO-2P-Im for Chemoprevention of the ARDS of COVID-19
$249,799Michael B Sporn · Triterpenoid Therapeutics, Inc. · R43 · FY2020 · CA
Adjuvants and Virosomal Vaccines for the Elderly
$249,748Janet E. McElhaney · University Of British Columbia · U01 · FY2007 · AI
A revised model for immune imprinting by influenza virus
$249,731Andrea Janine Sant · University Of Rochester · R21 · FY2022 · AI
INFLUENZA RISK
$249,650University Of Connecticut Sch Of Med/Dnt · M01 · FY2005 · RR
Mechanisms of dysregulated immunity with aging
$249,600Daniel Robert Goldstein · University Of Michigan At Ann Arbor · R01 · FY2020 · AG
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$249,587Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2025 · AI